Publications by authors named "C Cochet"

Article Synopsis
  • CK2 is an important enzyme involved in cell growth and survival, making it a potential target for cancer treatments, but many existing inhibitors are not selective enough.
  • Researchers discovered a new compound, a dihydropyrido-thieno[2,3-d]pyrimidine derivative, which showed strong inhibitory activity against CK2α and was notable for its unique chemical structure.
  • The most effective compound, 10b, had an IC value of 36.7 nM and demonstrated good selectivity and cellular activity against certain cancer cell lines, outperforming existing inhibitors in terms of inducing cell death.
View Article and Find Full Text PDF

Unlabelled: While mineral weathering (MWe) plays a key role in plant growth promotion and soil fertility, the molecular mechanisms and the genes used by bacteria to weather minerals remain poorly characterized. Acidification-based dissolution is considered the primary mechanism used by bacteria. This mechanism is historically associated with the conversion of glucose to protons and gluconic acid through the action of particular glucose dehydrogenases (GDH) dependent on the pyrroquinoline quinone (PQQ) cofactor.

View Article and Find Full Text PDF

Approximately one-third of advanced renal cell carcinoma (RCC) patients develop osteolytic bone metastases, leading to skeletal complications. In this review, we first provide a comprehensive perspective of seminal studies on bone metastasis of RCC describing the main molecular modulators and growth factor signaling pathways most important for the RCC-stimulated osteoclast-mediated bone destruction. We next focus on newer developments revealing with in-depth details, the bidirectional interplay between renal cancer cells and the immune and stromal microenvironment that can through epigenetic reprogramming, profoundly affect the behaviors of transformed cells.

View Article and Find Full Text PDF

Although the involvement of protein kinase CK2 in cancer is well-documented, there is a need for selective CK2 inhibitors suitable for investigating CK2 specific roles in cancer-related biological pathways and further exploring its therapeutic potential. Here, we report the discovery of AB668, an outstanding selective inhibitor that binds CK2 through a bivalent mode, interacting both at the ATP site and an allosteric αD pocket unique to CK2. Using caspase activation assay, live-cell imaging, and transcriptomic analysis, we have compared the effects of this bivalent inhibitor to representative ATP-competitive inhibitors, CX-4945, and SGC-CK2-1.

View Article and Find Full Text PDF